Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

NDORMS Professor of Musculoskeletal and Surgical Science, David Beard, has been named National Institute of Health Research (NIHR) Senior Investigator.

David Beard

The NIHR describes its Senior Investigators as among the “most prominent and prestigious researchers” and “most outstanding leaders of patients and people-based research within the NIHR research community.”

David has been named Senior Investigator in recognition of his outstanding leadership in research.

On being recognised as a Senior Investigator, David said “It is always an honour and privilege to be personally named as an NIHR Senior Investigator and in some ways ratifies many years of dedication and hard work.  However, I would like this award to be also badged to anyone (in any capacity) who has worked or helped me along the way (including those who already have the award – and we have a good number in the Division!).  The NIHR is a truly excellent organisation and I am extremely proud to have been recognised by them.  It is going to help me continue to lead (hopefully) top quality health related research into the future.”

David is also Rosetrees Director of the Royal College of Surgeons (RCS) Surgical Intervention Trials Unit (SITU-NDORMS) and one of the five RCS Chairs in Surgical Trials in the UK. He is responsible for a portfolio of surgical and complex intervention trials, many as co-applicant and some as Chief Investigator.

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.